Literature DB >> 2751124

Endothelium-dependent effects of halothane, enflurane, and isoflurane on isolated rat aortic vascular rings.

D J Stone1, R A Johns.   

Abstract

To determine the endothelium-dependent vascular effects of halothane, enflurane, and isoflurane, isometric tension was recorded in isolated ring preparations of rat thoracic aorta suspended in Kreb's buffer and aerated with 95% O2/5% CO2. One set of the rings had intact endothelium and the other set of the rings had the endothelium mechanically denuded. The rings were precontracted with phenylephrine (1 x 10(-6) M). Halothane, enflurane, or isoflurane gas was bubbled through the baths at increasing concentrations (0.5-5.0%) in preparations with and without indomethacin (28 microM). Endothelium-intact rings demonstrated significant (P less than 0.05) vasoconstriction at low concentrations of both isoflurane and enflurane followed by vasodilation at higher concentrations. Halothane also induced vasoconstriction in some rings, but its mean effect was not significantly different from control. After discontinuation of the anesthetic gas, endothelium-intact rings demonstrated a rebound vasoconstriction above previous maximal levels for all three anesthetics. When indomethacin was added to the baths, the vasoconstriction was potentiated and was statistically significant for all three anesthetics. These results suggest that at low concentrations, enflurane and isoflurane cause vasoconstriction through inhibition of basal EDRF production and/or stimulation of the release of an endothelium-derived constricting factor. At higher anesthetic concentrations, a direct vasodilating effect of the anesthetic predominates. The potentiation of vasoconstriction in the presence of indomethacin suggests that these volatile anesthetics stimulate the release of a vasodilating prostanoid from endothelium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751124     DOI: 10.1097/00000542-198907000-00021

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  9 in total

1.  Attenuation of contraction of isolated canine coronary arteries by enflurane and halothane.

Authors:  G A Blaise; J M Hughes; J C Sill; J N Buluran; G Caille
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

2.  Multiple actions of halothane on contractile response to noradrenaline in isolated mesenteric resistance arteries.

Authors:  J Yoshino; T Akata; K Izumi; S Takahashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-13       Impact factor: 3.000

3.  Volatile anaesthetic actions on norepinephrine-induced contraction of small splanchnic resistance arteries.

Authors:  T Akata; K Kodama; S Takahashi
Journal:  Can J Anaesth       Date:  1995-11       Impact factor: 5.063

4.  Differential vascular reactivity of canine mesenteric arteries and veins to sevoflurane.

Authors:  Kazu-Ichi Yoshida; Akiyoshi Ohsawa
Journal:  J Anesth       Date:  1998-03       Impact factor: 2.078

Review 5.  Vasodilators during cerebral aneurysm surgery.

Authors:  K Abe
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

Review 6.  Endothelial vasomotor regulation in health and disease.

Authors:  N R Searle; P Sahab
Journal:  Can J Anaesth       Date:  1992-10       Impact factor: 5.063

7.  Vascular aging and hemodynamic stability in the intraoperative period.

Authors:  Ferrante S Gragasin; Stephane L Bourque; Sandra T Davidge
Journal:  Front Physiol       Date:  2012-04-02       Impact factor: 4.566

8.  Endothelium-dependent vasodilation effects of Panax notoginseng and its main components are mediated by nitric oxide and cyclooxygenase pathways.

Authors:  Yanyan Wang; Yu Ren; Leilei Xing; Xiangdong Dai; Sheng Liu; Bin Yu; Yi Wang
Journal:  Exp Ther Med       Date:  2016-11-09       Impact factor: 2.447

9.  TRPA1 and TRPV1 contribute to propofol-mediated antagonism of U46619-induced constriction in murine coronary arteries.

Authors:  Pritam Sinharoy; Ian N Bratz; Sayantani Sinha; Loral E Showalter; Spencer R Andrei; Derek S Damron
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.